NGF and myeloid sarcoma: The aim of our review is to discuss some relevant examples of the proposed field of new research, focusing on the removal of pathogenic circulating factors and altering the plasma levels of nerve growth factor (NGF) and sphingosine-1-phosphate (S1P) by TPE and their impact on MS dysregulations.